Form 8-K Bioventus Inc. For: May 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/24/2026
- Wall St set for higher open after tech rout; Mideast, tariffs in focus
- Intel jumps 10% after AI-fueled quarter crushes estimates, upbeat outlook
- Oil retreats from above $100, still set for weekly rise on Middle East escalation
- Meta’s new seller app hits eBay where it hurts most
- Pullback in chip stocks is a buying opportunity, Citi says
Bioventus reiterates 2026 guidance after FDA device reclassification
May 21, 2026 5:14 PM EDTBioventus Inc. (NASDAQ: BVS) said it expects to maintain its 2026 financial guidance following regulatory changes affecting its bone healing device.
The U.S. Food and Drug Administration issued a final order on April 16, 2026, reclassifying non-invasive bone growth stimulators from Class III to Class II devices.... More
